Magenta Therapeutics, Inc.
USD0.70
-0.06 (-7.74%)
CEO
Stephen F. Mahoney MBA
IPO Date
2018-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.71
Prev. Close
$0.76
Day Low
$0.69
Day High
$0.76
52W Low
$0.32
52W High
$1.81
Market Cap
$0.04B
Volume
0.38M
| Acquired |
| 30,000 |
| $13.15 |
| 21 Sept 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | P-Purchase | Acquired | 30,000 | $13.20 |
| 13 Sept 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | P-Purchase | Acquired | 9,367 | $11.76 |
| 13 Sept 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | P-Purchase | Acquired | 14,887 | $10.85 |
| 13 Sept 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | Acquired | 6,500 | $11.20 |
| 13 Sept 2023 | Fairmount Funds Management LLC | director, 10 percent owner: | Disposed | 0 | $0.00 |
| 13 Sept 2023 | CARR EDWARD | CHIEF ACCOUNTING OFFICER | Disposed | 95,974 | $8.44 |
| 13 Sept 2023 | Soteropoulos Paula | director | A-Award | Acquired | 6,500 | $11.20 |
| 13 Sept 2023 | Soteropoulos Paula | director | Disposed | 28,792 | $8.44 |